Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Recruiting · NCT05125055 · Registry updated 2023-11-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Oral Squamous Cell Carcinoma, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 / Phase 3 | 2023-11-22 | NCT05125055 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Jiao Tong University School of Medicine | 117 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 2 |